Schedule 13D/G History

Panacea Innovation Ltd - Significant Ownership

Signature - Title: Panacea Innovation Limited - James Huang, Founding Managing Partner
Location: Grand Cayman, Cayman Islands
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Panacea Innovation Ltd.

Significant Ownership of Panacea Innovation Ltd

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ATRA	Atara Biotherapeutics, Inc.	Common Stock, par value $0.0001 per share	9.5%	$3.27M		550K		Panacea Venture Healthcare Fund II, L.P.	Jan 30, 2025
ADAG	Adagene Inc.	Ordinary Shares	5.5%	$4.74M		3.04M		Panacea Venture Healthcare Fund II, L.P.	Dec 31, 2024
AMLX	Amylyx Pharmaceuticals, Inc.	Common Stock, par value $0.0001 per share	2.6%	$7.79M		2.2M		Panacea Venture Healthcare Fund II, L.P.	Dec 31, 2024
MRNS	Marinus Pharmaceuticals, Inc.	Common Stock	0%	$0		0		Panacea Venture Healthcare Fund II, L.P.	Dec 31, 2024

Schedules 13D/G Reported by Panacea Innovation Ltd:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed

* An asterisk sign (*) next to the price indicates that the price is likely invalid.